2 Excellent Dividend Stocks to Buy on the Dip AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN) have a lot in common. They are both leading drugmakers and have strong…
Astrazeneca: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform AMSTERDAM/LONDON (dpa-AFX) - Der britische Pharmakonzern Astrazeneca darf sein Lungenkrebsmedikament Tagrisso in der EU in einer weiteren Indikation verkaufen.…
AZNs Tagrisso Gets Approval in the EU for Expanded Use in NSCLC AstraZeneca wins approval in the EU for the label expansion of Tagrisso to treat adult patients with locally advanced, unresectable…
Is AstraZeneca Stock a Buy? U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were…
Is Recursion Pharmaceuticals Stock a Millionaire Maker? Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…